| Gene symbol | PCSK9 | Synonyms | FH3, FHCL3, HCHOLA3, LDLCQ1, NARC-1, NARC1, PC9 | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1p32.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | proprotein convertase subtilisin/kexin type 9 | ||||
| GTO ID | GTC1708 |
| Trial ID | NCT03087591 |
| Disease | Colorectal Cancer | Colorectal Carcinoma | Pancreatic Carcinoma | Solid Neoplasm | Pancreatic Cancer | Metastatic Malignant Neoplasm |
| Altered gene | PCSK9 |
| Therapeutic/Target gene | Target gene |
| Therapy | siRNA |
| Treatment | APN401 |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | Safety and Immunologic Activity of Multiple Infusions of APN401 |
| Year | 2017 |
| Country | United States |
| Company sponsor | Wake Forest University Health Sciences |
| Other ID(s) | IRB00041173|NCI-2017-00050|CCCWFU 03716|P30CA012197 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||